Xarelto okayed by FDA for treating atrial fibrillation - CBS News

The FDA approved Xarelto, a next-gen blood thinner, for atrial fibrillation treatment, offering an alternative to warfarin. Xarelto, effective once daily, blocks clotting protein factor Xa, similar in stroke prevention to warfarin but with a boxed warning against abrupt discontinuation due to stroke risk.